LIVE WEBINAR
The use of AI & Agents: Modernization of the Clinical Data flow — Expectation & Reality
Is Clinical Data flow modernization through AI & Analytics a reality?
With increasing demands for speed, transparency, and growing data complexity there are big hopes on advanced AI in data validation and transformation.
Our experts will share insights on overcoming regulatory, technological, and organizational challenges to ensure that your clinical data flow is future ready. We will discuss practical approaches, timelines, and considerations for incorporating GenAI and Agentic capabilities into clinical data strategies.
Join us at this webinar and learn how AI agents are no longer experimental but are enabling near real-time insights across global trials.
26th November 2025, Wednesday
15:30 - 16:30 IST
11:00 - 12:00 CET
About our Presenters
Dr. Mark Lambrecht
Global Director, Health Care and Life Sciences
SAS Institute
Dr. Mark Lambrecht has more than 20 years of experience studying and implementing the potential, use and future of analytics, artificial intelligence and data engineering to advance patient outcomes. He is responsible for the global health care and life sciences market strategy of SAS. Mark likes to discuss how leaders in government, hospitals, payers and pharmaceutical manufacturers can take AI, real world evidence and digital healthcare from hype to reality, without oversimplifying clinical, financial and operational complexity.
Prior to joining SAS, Mark worked in the pharmaceutical industry and studied at the KU Leuven, Belgium and at Stanford University, USA. He holds a PhD and Master in Bioscience Genetic Engineering from the KU Leuven.
Mark Lambrecht is an expert in the application of AI, analytics and data engineering to the healthcare and life sciences sector, and particularly how technology can improve patient outcomes.
Thirupathi Pattipaka
Global Director, Data Science & AI
Novartis Switzerland
Experienced technology and data science leader with a strong track record in driving AI, machine learning, and real-world evidence (RWE) strategies across healthcare and life sciences. Proven expertise in building scalable, secure, and high-performing data and technology platforms, leading high-impact teams, and aligning AI and data capabilities with business growth. Passionate about leveraging advanced analytics and AI to transform drug development, medical affairs, market access, and patient outcomes. Skilled in stakeholder engagement, strategic partnerships, and delivering innovation in regulated environments.
Frequent speaker at global AI/RWE forums with 30+ scientific contributions and a strong commitment to ethical, responsible, and impactful AI. Currently serving as Global Director of Data Science & AI at Novartis, developing and implementing AI strategy to build AI solutions that can be impactful across Research, Development and commercial organizations.
Parag Limaye
Managing Director,
Deloitte Consulting